Abcepta is a leading provider of highly validated antibodies for the research community. Abcepta's catalog of 16,000+ antibodies cover a wide range of targets in cancer, neuroscience, metabolism, immunology, and developmental biology. Abcepta offers custom services for polyclonal and monoclonal antibody development, including anti-drug antibodies, as well as peptide synthesis.